Overview

Dexmedetomidine Adjuvant in Retinal Surgery

Status:
Unknown status

Trial end date:
2015-05-01

Target enrollment:
0

Participant gender:
All

Summary

During LA in retinal surgery there is some problem as regard the lack of anaesthesia duration and unexpected globe movement .so many adjuvant was added to LA to overcome this disadvantages of LA such as clonidine and fentanyl . The investigators hypothesis is adding dexmedetomidine to pribulbal blocking LA will prolong anaesthesia duration and improve globe akinesia and decrease intraoperative supplementation of LA.There are Many studies had described the effects of dexmedetomidine on peripheral nerve blocks, spinal but up to date no knowledge is available on the impact of dexmedetomidine adjuvant to local anaesthetic in ophthalmic surgery

Phase:

Phase 3

Accepts Healthy Volunteers?

Details

Lead Sponsor:

King Saud University

Treatments:

Anesthetics
Dexmedetomidine

Criteria

Inclusion Criteria:

- Adult patients

- Going for elective vitreoretinal surgery.

Exclusion Criteria:

- History of coagulation abnormalities.

- Allergy to local anesthetics.

- Cardiac, hepatic or renal failure,

- Chronic clonidine or analgesic therapy.

- One-eyed patients